We have shown that 30% CR significantly decreases incidence of pancreatitis-induced and Kras-induced pancreatic cancer in genetically engineered mouse models (GEMMs), largely through reduction of circulating levels of IGF-1 [25], [26], [27]. Here, IGF1 is linked to pancreatic neoplasm.